Laden…
2-(methylamino)-1-(3-methylphenyl)propan-1-one
3-Methylmethcathinone is a substance from the class of cathinones. Further information will follow after enrichment.
Class
Stimulants
Pharmacological context
Mechanism
3-MMC (3-Methylmethcathinon) ist ein Cathinon-Derivat und...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Designations
IUPAC: 2-(methylamino)-1-(m-tolyl)propan-1-one
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology is partially translated. Some details are still being expanded.
3-MMC (3-Methylmethcathinon) ist ein Cathinon-Derivat und Substrat-Typ-Releasor. Wirkt primär am SERT (Serotonin-Freisetzung > Reuptake-Inhibition) mit moderater NET- und DAT-Aktivierung. Pharmakologisch ähnlich wie Mephedron (4-MMC), jedoch schwächer serotonerg. Die Substrat-Typ-Aktivität (Reverse-Transport) unterscheidet 3-MMC von reinen Reuptake-Inhibitoren wie MDPV. Kurze Halbwertszeit (1-3h) erzeugt Redosierungsmuster. Empathogens Effekte bei niedrigen Dosen, stimulierend bei höheren Dosen.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 20–40 mg
Total duration 4–8 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 10–20 mg |
| Reported | 20–40 mg |
| Strong | 40–80 mg |
Nasal
| Tier | Dosage |
|---|---|
| Light | 5–15 mg |
| Reported | 15–30 mg |
| Strong | 30–60 mg |
Onset
30–60 minutes
Peak
1–2 hours
Total duration
4–8 hours
After effects
2–4 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Neurotoxicity
possible
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.